Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

61 results about "Chloral hydrate" patented technology

This medication is used to calm you just before surgery or other procedures.

Chloral hydrate permeabilization flaking method in microscopic identification of TCM

The invention relates to a chloral hydrate permeabilization flaking method in microscopic identification of TC, which can effectively solve the problem of easy control, high efficiency and safety of chloral hydrate permeabilization. The method comprises the following steps: adding water in chloral hydrate for dissolving to obtain a chloral hydrate solution with mass concentration of 30-50%; adding 0.1-0.5g of traditional Chinese medicinal material powder into 2ml of chloral hydrate solution with mass concentration of 30-50% to prepare a mixture; filling the mixture into a container, preheating to 100-110 DEG C, then heating to 125-135 DEG C for 4-8 minutes, realizing permeabilization of the mixture; dropping the 1-2 drops of permeabilized mixture on a slide glass, adding 1-2 drops of dilute glycerin, uniformly mixing the traditional Chinese medicinal material powder on the slide glass, covering a coverslip, using an absorbent paper to remove overflowed liquid, and keeping the clean coverslip and slide glass. The flaking method can be effectively used for chloral hydrate permeabilization, and has the advantages of energy saving, safety, high efficiency, controllable performance, wide application and environmental protection, is especially suitable for teaching and scientific research, has strong utility value, and is great innovation of chloral hydrate permeabilization flaking method.
Owner:HENAN UNIV OF CHINESE MEDICINE

Stable chloral hydrate solution and preparation method and application thereof

The invention discloses a chloral hydrate solution. The chloral hydrate solution comprises chloral hydrate, pharmaceutically-acceptable acid and water, wherein the mass concentration of the chloral hydrate is 40-80%, and the pH value of the chloral hydrate solution is preferably 1.0-2.9. Particularly, the invention relates to a stable chloral hydrate solution. The stable chloral hydrate solution comprises chloral hydrate, monohydrate or anhydrous citric acid and purified water, wherein the mass concentration of the chloral hydrate is 44-80%, and the pH value of the chloral hydrate solution ispreferably 1.0-2.9. The invention further relates to a preparation method and application of the chloral hydrate solution.
Owner:TEFENG PHARM CO LTD

Preparation method of acetic acid inducted rat individual same-size gastric ulcer model

The invention relates to a manufacturing method of a single and isometric gastric ulcer model induced by acetic acid in a rat. The method comprises procedures as follows: the rat is fasting but drinks freely for 24 hours; the chloral hydrate of 10 percent (0.3nl/100g weight) is used for anesthetizing the rat by muscle administration; lodophor is used for sterilizing the abdomen skin of the rat; a cut is made on the side wall of the abdomen and a stomach is pulled out slightly; the nipper with an annular front end (with the inner diameter of 9mm) clamps a corpus ventriculi part 3mm away from a pyloric part; after a distal stomach-antrum is penetrated, 0.81ml of the mineral oil and the acetic acid solution of 160 percent of 0.02ml ( with the total volume of 0.2ml) are injected into a lumen; after 45 seconds, the mixed solution of acetic acid and the mineral oil is absorbed from stomach; afterwards, the physiological saline of 2ml is injected into a gastral cavity for flushing and is drained off after 1min; and at last, the stomach is put back and the abdomen is sewed up. After an operation, the rat is carried out usual care. The method is easy to be handled and can make a single round ulcer with the inner diameter of 9mm. The area and the depth of the ulcer can be controlled. In addition, the problem of adhesion can be solved; the ulcer is extremely similar with the human ulcer in pathological features and healing mechanism; and the ulcer model is very sensitive to various anti-ulcer drugs.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE

Administration method and administration device for experimental animal brain

InactiveCN104274255ASolve the problem of relatively large physical damageEasy injectionVeterinary instrumentsHeterocyclic compound active ingredientsDrugs solutionPenicillin
The invention discloses an administration method for an experimental animal brain; by adopting a method for burying a catheter into the experimental animal brain, injection to the experimental animal brain is more convenient. According to the administration method, a special successive administration device is adopted, and a mouse or a rat is taken as an experimental animal, and the administration method comprises the following steps: 1, narcotizing the experimental animal with 30 percent of chloral hydrate, fixing the experimental animal on a mouse brain locator, and determining the position of a paracele; 2, burying an administration catheter into the paracele of the experimental animal according to the step, and fixing the catheter to the head of the experimental animal by dental cement when cerebrospinal fluid overflows from the catheter; 3, in 4 days after the catheter is buried successfully, performing successive intramuscular injection every day with 0.2ml of 0.8 million units of penicillin sodium, and diminishing inflammation of the experimental animal; 4, performing administration: sucking up a right amount of to-be-experimented drug solution by a 10mul microinjector, and partially inserting the syringe needle of a microsyringe into the catheter buried into the experimental animal brain, wherein the insertion depth is 0.5-2.0cm, and successive administration can be performed on the mice brain from the catheter.
Owner:SHENYANG PHARMA UNIVERSITY

Preparation method of bacillus cereus polyclonal antibodies

The invention provides a preparation method of bacillus cereus polyclonal antibodies, which comprises the following steps: 1, enrichment: coating activated bacillus cereus on a flat plate for enlarge cultivation; 2, fixation: fixing surface compositions of the bacillus cereus by using a modified boiling water bath method, so that antigenic determinants are fully exposed; 3, emulsification: preparing a uniform emulsified liquid from an adjuvant-bacillus mixture by using a self-assembled emulsifier; 4, immunization: carrying out animal immunization in a mode of being based on multiple loca on the back and supplemented by peripheral loca; 5, antiserum titer: evaluating the antiserum titer by using an ELISA method, and carrying out enhanced immunization; 6, taking whole blood: taking whole blood from cervical arteries under the condition of anesthesia by using chloral hydrate; 7, preparation of antiserum: standing the rabbit whole blood at optimum temperature so as to carry out natural chromatography, and carrying out centrifugal separation on the antiserum; and 8, purification: purifying the antiserum by using an n-caprylic acid-ammonium sulfate method, so that a polyclonal antibody is prepared. The polyclonal antibody prepared by using the preparation method disclosed by the invention is high in titer, good in specificity and strong in sensitivity, and has a great application advantage.
Owner:FUDEAN OF BEIJING TECH +1

Chronic thromboembolic pulmonary hypertension rat model and building method thereof

InactiveCN108836552ASurgical veterinaryLeft internal jugular veinThrombus
The invention belongs to the technical field of a new variety of vertebrates, and discloses a chronic thromboembolic pulmonary hypertension rat model and a building method thereof. Chloral hydrate ata concentration of 10 percent is injected through the abdominal cavity for anesthesia; under a sterile condition, through a left internal jugular vein, 1.5 mL of tranexamic acid-containing normal saline mixed with about 32 + / - 5 autologous thromboemboli embolizes the pulmonary artery at a rate of 0.5 ml / min; the rat is slowly turned in the embolizing process to enable a larger number of emboli toenter the lung circulation of the rat; after being embolized, the rat has cyanosis and breathes faster; on the fourth day and the eleventh day of the embolization, the rat is embolized for the secondtime and the third time according to the same method; the rat is observed for 5 weeks. The CTEPH model built by the building method disclosed by the invention takes the autologous emboli of the rat asemboli to embolize the pulmonary artery and enables the autologous emboli to embolize a blood vessel as long as possible under the help of pro-inflammatory effect of carrageenin, so as to really model the whole pathophysiological process of pulmonary embolism secondary CTEPH of a clinical CTEPH patient.
Owner:THE FIRST AFFILIATED HOSPITAL OF FUJIAN MEDICAL UNIV

Method for constructing temporomandibular joint osteoarthritis animal model by applying digital technology

The invention discloses a method for constructing a temporomandibular joint osteoarthritis animal model by applying a digital technology, relates to the technical field of medicine and animal models, and solves the problem that an existing animal model construction method is poor in intuition, poor in precision and poor in expected controllability, resulting in that a model sample is easy to generate heterogeneity. The method for constructing the temporomandibular joint osteoarthritis animal model by applying the digital technology comprises the steps of: selecting an SD rat, anesthetizing, and digitally scanning animal teeth; selecting a 6-week-old female SD rat with the weight of 160-180 g, feeding the rat in a clean environment, adaptively feeding the rat for one week, injecting 10% chloral hydrate into the abdominal cavity of the SD rat, and anesthetizing the rat; producing a telescopic crown; establishing the temporomandibular joint osteoarthritis animal model; and under the anesthesia of chloral hydrate, adhering by zinc phosphate cement. The method applies the digital technology, is simple in production process, more visual in 3D scanning and high in precision, has predictability, and avoids heterogeneity of samples.
Owner:JIAMUSI UNIVERSITY

Sample pretreatment method for detecting content of chloral hydrate in health care product and detection method of chloral hydrate

PendingCN114705768AReduce processing timeSimplify the detection and analysis processComponent separationSeparation technologyChloride
The invention relates to a sample pretreatment method for detecting the content of chloral hydrate in a health-care product and a detection method of the chloral hydrate. The sample pretreatment method for detecting the content of chloral hydrate in the health care product comprises the following steps: taking a proper amount of sample, adding an acid solution, heating, and decomposing chloral hydrate to generate HCl and HCOOH gases; and absorbing the generated gas with water to obtain a solution to be detected. According to the method, chloral hydrate can be subjected to a hydrolysis reaction under acidic and heating conditions and generate hydrogen chloride and formic acid with high volatility, then the hydrogen chloride and the formic acid are separated by combining a gas-liquid separation technology, and the content of chloral hydrate in the health care product is determined by adopting an analysis technology for detecting chloride ions or formic acid. Compared with the prior art, the sample pretreatment method for detecting the content of chloral hydrate in the health care product and the detection method of the sample pretreatment method have the advantages that matrix interference can be effectively eliminated, the sample pretreatment time is shortened, the detection and analysis process of chloral hydrate in the health care product is greatly simplified, the steps are simple, and the sensitivity is high.
Owner:GUILIN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products